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Background: It has been recently noticed that type 2 dia-
betes (T2D), one of the most common metabolic diseases, 
causes a chronic low-grade inflammation and activation of 
the innate immune system that are closely involved in the 
pathogenesis of T2D. Cordyceps militaris, a traditional me-
dicinal mushroom, produces a component compound, cordy-
cepin (3’-deoxyadenosine). Cordycepin has been known to 
have many pharmacological activities including immuno-
logical stimulating, anti-cancer, and anti-infection activities. 
The molecular mechanisms of cordycepin in T2D are not 
clear. In the present study, we tested the role of cordycepin 
on the anti-diabetic effect and anti-inflammatory cascades in 
LPS-stimulated RAW 264.7 cells. Methods: We confirmed 
the levels of diabetes regulating genes mRNA and protein of 
cytokines through RT-PCR and western blot analysis and fol-
lowed by FACS analysis for the surface molecules. Results: 
Cordycepin inhibited the production of NO and pro-in-
flammatory cytokines such as IL-1β, IL-6, and TNF-α in 
LPS-activated macrophages via suppressing protein ex-
pression of pro-inflammatory mediators. T2D regulating genes 
such as 11β-HSD1 and PPARγ were decreased as well as 
expression of co-stimulatory molecules such as ICAM-1 and 
B7-1/-2 were also decreased with the increment of its 
concentration. In accordance with suppressed pro-in-
flammatory cytokine production lead to inhibition of diabetic 
regulating genes in activated macrophages. Cordycepin sup-
pressed NF-κB activation in LPS-activated macrophages. 
Conclusion: Based on these observations, cordycepin sup-
pressed T2D regulating genes through the inactivation of 
NF-κB dependent inflammatory responses and suggesting 
that cordycepin will provide potential use as an immunomod-
ulatory agent for treating immunological diseases.
[Immune Network 2009;9(3):98-105]
INTRODUCTION
Obesity  is  the  most  common  metabolic  disease  in  the  in-
dustrial world (1). The prevalence of obesity is increasing at 
an alarming rate along with its associated morbidities, such 
as atherosclerosis and type 2 diabetes (2). Diabetes mellitus 
is a metabolic disorder of the endocrine system that is found 
in all parts of the world and is rapidly increasing in most parts 
o f  t h e  w o r l d  ( 3 ) .
    Type  2  diabetes  mellitus,  non-insulin-dependent  diabetes 
mellitus  (NIDDM),  accounts  for  more  than  90%  of  diabetes 
patients. Insulin resistance in peripheral tissues leads to com-
pensatory hyperinsulinemia, followed by β-cell failure, leading 
first  to  prandial  and  later  to  overt  fasting  hyperglycemia  (4).
    Recent studies have indicated that obesity is associated with 
a chronic inflammation state, suggesting that inflammation is 
a potential mechanism by which obesity leads to insulin re-
sistance (5). The authors reported that adipocytes, especially 
in  the  obese,  secrete  a  number  of  pro-inflammatory  cyto-
kines, some of which have been shown to directly inhibit in-
sulin signaling. Adipocytokines probably act through master 
pro-inflammatory regulators, such as those of the NF-κB and 
JNK/AP-1 signaling pathways to modulate the expression of 
genes coding for many inflammatory proteins and to alter in-Cordycepin Suppresses Expression of Diabetes Regulating Genes by Inhibition of Inflammation
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Figure 1. Chemical structure of cordycepin. 
sulin  signaling. 
    Macrophages, which are a type of differentiated tissue cell 
that originate as blood monocytes, play an important role in 
immune and allergic reactions as well as in inflammation (6). 
These cells have several functions including the killing and 
removal of pathogenic microbes and the processing and pre-
sentation  of  antigens  ingested  by  lymphocytes  (7).
  Cordyceps militaris is known as the rare Chinese caterpillar 
fungus (8) and has benefits to the human body including the 
circulatory, immune, respiratory, and glandular systems. Cordy-
cepin (Fig. 1), 3’-deoxyadenosine, is a major component of 
cordyceps  millitaris  and  a  derivative  of  the  nucleoside  ad-
enosine only differing from the latter by the absence of oxy-
gen in the 3’ position of its ribose entity (9). Cordycepin has 
been studied for anti-tumor (10), anti-inflammatory (11), an-
ti-diabetic (12), and renoprotective effects (13). Even though 
cordycepin demonstrates a number of pharmacological prop-
erties, further studies are necessary to address these pharma-
cological  differences.
    The manner by which macrophages induce insulin resist-
ance in inflammatory responses has not been established, as 
yet. Macrophages secrete factors induce inflammation in adi-
pose tissue and influence insulin sensitivity, but the specific 
factors involved, and mechanisms by which they exert these 
effects,  remain  unknown.  In  this  study,  we  tested  the  role 
of  cordycepin  on  the  NF-κB-dependent  inflammation  cas-
cades  and  inhibition  of  diabetes  regulating  genes  in  lip-
opolysaccharide  (LPS)-stimulated  RAW  264.7  cells.
MATERIALS AND METHODS
Reagents
Cordycepin  and  lipopolysaccharide  (LPS)  were  purchased 
from Sigma (St. Louis, USA). The cell culture media DMEM, 
antibiotic-penicillin/streptomycin solution and fetal bovine se-
rum (Hyclone, Logan, USA) were used for the cell culture.
Cell culture
M u r i n e  m a c r o p h a g e s  c e l l  l i n e  ( R A W  2 6 4 . 7 )  w a s  o b t a i n e d  
from  the  American  Type  Culture  Collection  (ATCC).  Cells 
were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with high glucose, L-glutamine, 110 mg/L so-
dium pyruvate, 10% fetal bovine serum (FBS), and 1% (v/v) 
penicillin  (10,000  U/ml)/  streptomycin  (10,000  U/ml)  (P/S). 
The cells were stimulated with LPS (100 ng/ml) in the pres-
ence  of  cordycepin  for  24  hr  at  a  concentration  2×10
5 
cells/well/200μl of media on 96-well plates for the NO assay.
MTT assay for cell viability
A commercially-available cell viability assay was employed to 
evaluate  the  cytotoxic  effect  of  cordycepin  using  thiazolyl 
blue tetrazolium bromide (Sigma, St. Louis, USA). RAW264.7 
cells  (2×10
5  cells/well)  were  plated  with  various  concen-
trations  of  cordycepin  in  96-well  microtiter  plates  (Nunc, 
Roskilde, Denmark) and were then cultured overnight at 37
oC 
in a 5% CO 2 incubator. Afterwards, 50μl of MTT solution was 
added to each well, and the cells were then cultured for 4 
hrs at 37
oC in a 5% CO2 incubator. 100μl of solubilized sol-
u t i o n  w e r e  a d d e d  t o  e a c h  w e l l .  T h e  p l a t e  w a s  a l l o w e d  t o  
stand overnight in the incubator after evaluation for complete 
solubilization of the purple formazan crystals and the meas-
urement of the optical density (OD) at 560 nm by a micro-
plate reader (Molecular Devices corporation, Sunnyvale, USA).
Measurement of NO content
To assay the total production of NO, 100μl of each culture 
supernatant were incubated at room temperature for 10 min 
with  100μl  of  Griess  reagent  (stock-I:  0.2%  N-(1-naphthyl) 
ethylenediamine-HCl, stock-II: 2% sulfanilamide in 5% H2PO4). 
The O.D values of samples were read at 540 nm. A standard 
are curve using NaNo2 was then used to calculate the NO2
− 
concentration. 
Isolation of total RNA and RT-PCR
Total  RNA  was  extracted  from  RAW  264.7  cells  using  the 
RNeasy Mini kit (QIAGEN, USA) in an RNase-free environment. 
RNA was quantified by reading the absorbance at 260 nm as 
previously described (14). The reverse transcription of 1μg 
RNA  was  carried  out  using  M-MLV  reverse  transcriptase 
(Promega, USA), oligo (dT) 16 primer, dNTP (0.5μM) and 
1 U RNase inhibitor. After incubation at 65
oC for 5 min and Cordycepin Suppresses Expression of Diabetes Regulating Genes by Inhibition of Inflammation
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Figure 2. Effect of cordycepin on NO production in RAW 
264.7 cells. Cells were treated with different concentrations
of cordycepin; nitrite concentrations in the culture media were
determined using Griess reagent assay. The results are 
reported as mean±S.D. of 3 independent experiments. 
##p
＜0.01 vs. cells only based on Student’s t-test. **p＜0.01 vs.
cells only based on Student’s t-test.
37
oC for 60 min, M-MLV reverse transcriptase was inactivated 
by heating at 70
oC for 15 min. The polymerase chain reaction 
(PCR)  was performed in  50 mM KCl, 10  mM  Tris-HCl  (pH 
8.3), 1.5 mM MgCl2 and 2.5 mM dNTPs with 5 units of Taq 
D N A  p o l y m e r a s e  a n d  1 0  p M  o f  e a c h  p r i m e r  s e t  f o r  1 1 β- 
htdroxysteroid  dehydrogenase  type  1  (11β-HSD1),  perox-
isome proliferators-activated receptor γ (PPARγ), and regu-
lated  upon  activation  normal  T-cell  expressed  and  secreted 
(RANTES). The cDNA was amplified by 35 cycles of denatur-
ing at 94
oC for 45 s, annealing at 62
oC for 45 s, and extension 
at 72
oC for 1 min. Final extension was performed at 72
oC for 
5  min. The  PCR products were electrophoresed  on  a  1.5% 
agarose gels and stained with ethidium bromide. The primers 
used were 5' CAAGGCGGGAAAGCTCATGG 3' (forward) and   
5' GGAGGAGATGACGGCAATGC 3' (reverse) for 11β-HSD1, 
5' ATCATCCTCACTGCAGCCGC 3' (forward) and 5' CACACT-
T G G C G G T T C C T T C G  3 '  ( r e v e r s e )  f o r  R A N T E S ,  5 '  G A G C C T -
GTGAGACCAACAGC  3'  (forward)  and  5'  GATTCCGAAGT-
TGGTGGGCC  3'  (reverse)  for  PPARγ,  and  5'  GTGGGCC-
GCCCTAGGACCAG 3' (forward) and 5' GGAGGAAGAGGA-
TGCGGCAGT 3' (reverse) for β-actin. β-actin was used as 
an  internal  control.
Preparation of nuclear extracts
After culture the cells were collected and washed twice with 
cold PBS, resuspended in hypotonic buffer (10 mM HEPES, 
pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.2 mM PMSF, 0.5 mM 
DTT, 10μg/ml aportinin). After 15 min incubation on ice, the 
cells were lysed by the addition of 0.1% NP-40 and vigorous 
vortexing  for  1  min.  The  nuclei  were  pelleted  by  cen-
trifugation at 12,000×g for 1 min at 4
oC and resuspended in 
high salt buffer (20 mM HEPES, pH 7.9, 25% glycerol, 400 
mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 1 mM 
NaF, 1 mM sodium orthovanadate). The supernatant fluid was 
stored  in  aliquots  at  −70
oC.
Western blot analysis 
RAW 264.7 cells were washed with phosphate-buffered saline 
(PBS) and lysed by lysis buffer (1% SDS, 1.0 mM sodium va-
nadate, 10 mM Tris-Cl buffer, pH 7.4) for 5 min. 20μg of 
protein from the cell lysates was applied to 8∼12% SDS-poly-
acrylamide gels and then transferred to nitrocellulose mem-
branes. The membranes were blocked with 5% skim milk in 
PBST solution for 1 hr. They were then incubated with an-
ti-IL-1β,  anti-IL-6,  anti-TNF-α,  anti-i-NOS,  anti-COX-2,  and 
anti-NF-κ B  monoclonal  antibody  for  2  hrs  and  washed  3 
t i m e s  w i t h  P B S T .  A f t e r  i n c u b a t i o n  w i t h  a l k a l i n e  p h o s p h a -
tase-labeled secondary antibody for 2 hrs, the bands were vi-
sualized using a Western Blot Kit with alkaline phosphatase 
substrate  (Vector,  Burlingame,  USA).
Flow cytometry
RAW 264.7 cells (1×10
6 cells/ml) were cultures in Petri-dishes. 
The cells were treated with various concentration of cordyce-
pin (10, 20, 40μg/ml) in the presence of LPS (100 ng/ml). 
The dishes were incubated at 37
oC for 24 hrs in humidified 
5% CO2 incubator under standard conditions. The cells wash-
ed with PBS. The washed cells blocked with staining buffer 
containing 10% normal mouse serum (NMS) for 20 min on 
ice.  The  blocked  cells  were  incubated  with  co-stimulatory 
molecules  such  as  ICAM-1,  B7-1  and  B7-2  antibody  for  20 
min on ice. The incubated cells were washed with staining 
buffer at 3 times. The washed cells fixed by 1% paraformalde-
hyde  in  PBS.  The  fixed  cells  were  measured  by  flow  cy-
tometry  (Beckman  coulter,  Brea,  USA).
Data analysis  
D a t a  a r e  e x p r e s s e d  a s  m e a n ± s t a n d a r d  d e v i a t i o n .  S t a t i s t i c a l  Cordycepin Suppresses Expression of Diabetes Regulating Genes by Inhibition of Inflammation
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Figure 3. Effect of cordycepin on the expression of T2D
regulating genes in RAW 264.7 cells. Levels of 11β- 
HSD1, RANTES, and PPARγ mRNA in RAW 264.7. 
Cells were incubated with various concentrations of 
cordycepin in the presence of LPS (100 ng/mL) for 24
hrs. The mRNA levels of T2D regulating genes were 
determined by RT-PCR analysis. β-actin was used as a 
control.
Figure 4. Effect of cordycepin on the expression of 
pro-inflammatory cytokines (A) and related proteins (B) 
in RAW 264.7 cells. Levels of IL-1β, IL-6, and TNF-α
(A) and i-NOS and COX-2 (B) in RAW 264.7 cells. Cells 
were incubated with various concentrations of cordy-
cepin in the presence of LPS (100 ng/ml) for 24 hrs. 
Protein (20μg) from each sample was resolved in 8∼
12% SDS-PAGE and then analyzed by Western blotting.
β-actin was used as a control.
significance  between  the  groups  was  determined  by  paired 
t-test  and  one-way  ANOVA  for  repeated  measures.  Results 
with  p＜.05  were  considered  statistically  significant.  Data 
w e r e  a s s e s s e d  u s i n g  a n  S P S S  p r o g r a m  ( v e r s i o n  1 5 . 0 ,  S P S S  
Inc.,  Chicago,  Illinois).
RESULTS
Effect of cordycepin on cell viability 
To rule out the toxic effect of cordycepin, we tested its effect 
on the viability of RAW 264.7 by MTT assay. The exposure 
of cells to cordycepin at 5∼40μg/ml for 24 hr showed no 
significant adverse effect on the cell viability versus the un-
treated  control  (data  not  shown).
Reduction of NO production in LPS-stimulated RAW 
264.7 by cordycepin
In an effort to investigate the effect of cordycepin, we first 
confirmed whether cordycepin inhibits NO production in acti-
vated macrophages. The macrophages did not release NO in 
response  to  the  medium  alone;  LPS  (100  ng/ml)  was  used 
as a positive control for macrophage activation (Fig. 2). When 
various  concentration  of  cordycepin  (5,  10,  20,  40μg/ml) 
were added to the culture media in the presence of LPS (100 
ng/ml) at the time of cell stimulation (18 hrs), NO production 
was  decreased  in  a  cordycepin  concentration-dependent 
manner. 
Inhibition the gene expression of T2D regulating 
protein and chemokine by cordycepin  
To further investigate to important role of cordycepin on T2D, Cordycepin Suppresses Expression of Diabetes Regulating Genes by Inhibition of Inflammation
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Figure 5. Effects of cordycepin on the expression co- 
stimulatory molecule. RAW 264.7 cells were cultured 
with various concentrations of cordycepin (10, 20, 40μg/
ml) in the presence of LPS (100 ng/ml) for 24 hours. The
surface ICAM-1 (A), B7-1 (B), and B7-2 (C) molecules 
were labeled with either anti-ICAM-1, anti-B7-1/-2.
Figure 6. Effect of cordycepin on NF-κB activation. 
Levels of NF-κB protein in RAW 264.7 cells. Cells were
incubated with various concentrations of cordycepin in
the presence of LPS (100 ng/ml) overnight. Protein from
each sample was resolved in 12% SDS-PAGE and then 
analyzed by Western blotting. β-actin was used in as a
control.
murine macrophage cells with cordycepin (5∼40μg/ml) in 
the presence of LPS (100 ng/ml) for 24 hrs decreased T2D 
regulating genes. As shown in Fig. 3, cordycepin suppressed 
11β- H S D 1 ,  R A N T E S ,  a n d  P P A R γ expression  dose-depen-
dently.
Effect of cordeycepin on pro-inflammatory cytokines 
and related proteins
We  determined  the  intracellular  levels  of  pro-inflammatory 
c y t o k i n e s ,  a n d  r e l a t e d  p r o t e i n s  b y  w e s t e r n  b l o t  a n a l y s i s ,  
showing that cordycepin decreased IL-1β, IL-6, TNF-α, i-NOS, 
and  COX-2  in  a  dose-dependent  manner  (Fig.  4).
Regulated the surface expression levels of co-sti-
mulatory molecules 
The RAW 264.7 cell surface expression of ICAM-1, B7- 1, and 
B7-2 was examined by flow cytometry. As shown in Fig. 5, 
cordycepin inhibited cell surface molecules such as ICAM-1, 
B7-1, and B7-2 in a dose-dependent manner. LPS-stimulated 
RAW 264.7 treated with a high concentration of cordycepin 
(40μg/ml) had a greater reduction than other concentration.
Suppressed NF-κB activation by cordycepin
To investigate whether cordycepin could affect nuclear trans-
location of NF-κ B, western blot analysis for NF-κ B p65 was 
carried out with cell lysate in macrophages (Fig. 6). Amount 
of NF-κ B p65 was markedly increased upon exposure to LPS 
alone,  but  cordycepin  decreased  NF-κ B  p65.
DISCUSSION
The  data  presented  in  this  paper  indicated  that  cordycepin 
can exert significant anti-diabetic effects on macrophage-me-
diated  immune  responses.  The p r e s e n t  s t u d y  d e m o n s t r a t e d  
that cordycepin suppressed NO generation, cytokine (IL-1β, 
IL-6, and TNF-α) expression, and co-stimulatory molecules 
in RAW 264.7 cells. M1 macrophages exposed to the classic 
activation signals IFN-γ and LPS express opsonic receptors, Cordycepin Suppresses Expression of Diabetes Regulating Genes by Inhibition of Inflammation
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whereas M2 macrophages are characterized by abundant lev-
els of non-opsonic receptors (15). Inflammation is a complex 
process involving numerous mediators of cellular and plasma 
origins.  M1  macrophages  fuse  their  lysosomes  more  effi-
ciently to phagosomes, exposing intracellular or recently in-
gested extracellular microbes to a variety of microbiocidal ly-
sosomal enzymes. M1 macrophages also produce oxygen rad-
icals  and  NO,  both  of  which  have  potent  antimicrobial 
activity.
    Arginine metabolism is characterized by high levels of iNOS 
in M1 macrophages, whereas the arginase pathway predom-
inates in M2 polarized macrophages. NO is synthesized via 
the oxidation of arginine by a family of NOS and plays a vital 
role in regulating physiological processes, such as blood ves-
sel  tone  and  neurotransmission,  as  well  as  in  host  defense 
and  immunity  (16,17).  However,  increasing  evidence  in-
d i c a t e s  t h a t  N O S  p l a y s  a  c o m p l e x  r o l e  i n  m o d u l a t i n g  i n -
flammatory  response  (18).  Among  these  cytokines,  IL-1β, 
IL-6, and TNF-α, have attracted more attention in that they 
can be localized to the infected tissue, manifested systemically 
throughout the body and cause vasodilation as well as symp-
toms  of  inflammation,  such  as  redness,  swelling,  heat,  and 
pain  (19).
    Cordycepin  down-regulated  the  expression  of  pro-in-
flammatory  molecules  likewise  NO  in  LPS-stimulated  RAW 
264.7  cells  (Fig.  2)  and  when  we  examined  the  morpho-
logical changes that took place in macrophages treated with 
cordycepin and LPS, cells treated with LPS and low concen-
trations of cordycepin (5∼10μg/ml) were similar those ex-
posed to LPS alone. However, cells treated with high concen-
tration  of  cordycepin  (40μg/ml)  in  combination  with  LPS 
were smoother than those treated with LPS alone (data not 
shown). Also it inhibited the activation of pro-inflammatory 
cytokines  and  related  proteins  in  both  of  the  LPS-activated 
c e l l  t y p e s  ( F i g .  4 ) .
    Macrophages secreted anti-inflammatory cytokines by cor-
dycepin,  it  differentiate  M2  macrophages.  M2  macrophages 
are  generally  characterized  by  low  production  of  pro-in-
flammatory  cytokines  and  high  expression  of  scavenger  re-
ceptors (15). Cordycepin increased TG accumulation in mac-
rophages (Supplementary Fig. 1). It indicated that M2 macro-
phages  uptake  TG  from  circulation,  then  are  used  for  fuel 
(20).
    Expression of cytokines requires the activation of NF-κB. 
NF-κB ,  a  n u c l e a r  t r a n s c r i p t i o n  f a c t o r ,  r e g u l a t e s  t h e  e x -
pression of various genes, including IL-1β, i-NOS, and COX-2 
that play critical roles in apoptosis and autoimmune diseases. 
Its activation requires phosphorylation of IκB, by which lead 
IκB to ubiquitination and degradation. As shown in Fig. 6, 
cordycepin  decreased  pro-inflammatory  mediators  via  sup-
pression  of  NF-κB  activation  in  murine  macrophages.
    Growing evidence has pointed to a correlative and causa-
tive relationship between inflammation and insulin resistance. 
The  pro-inflammation  cytokines  such  as  TNF-α and  IL-6 
have been demonstrated to mediated insulin resistance as a 
result of obesity in many rodent obesity models (21,22). TNF-
α was  overexpressed  in  white a d i p o s e  t i s s u e  ( W A T )  i n  
obese an insulin-resistance states; mice lacking the TNF-α li-
gand or the p55 TNF receptor were partially protected from 
obesity-induced  insulin  resistance  (23).
    Increasingly, insulin resistance has been recognized as the 
integral feature of the so-called metabolic syndrome, which 
includes  glucose  intolerance,  insulin  resistance,  obesity,  hy-
pertriglyceridemia,  hypertension,  and  accelerated  athero-
sclerosis  (24).
    Glucocorticoids regulate adipocyte differentiation, function 
and distribution, and in excess, cause visceral fat obesity and 
convergence  of  metabolic  diseas e  ( 2 5 ) .  G l u c o c o r t i c o i d  r e -
ceptor (GR) is controlled by isozymes of 11β-HSD. Although 
two isoforms have been identified, it is 11β-HSD1 that has 
attracted attention with respect to therapeutic inhibition. 11β- 
HSD1 is a bidirectional enzyme that resides within the endo-
plasmic reticulum and is widely expression in many gluco-
corticoid target tissues including liver, adipose tissue where 
it acts locally to regenerate active cortisol from inactive corti-
sone  and  thereby  amplify  GR  activation  (26). 
    RANTES is increased in WAT in the setting of murine and 
human  obesity.  Both  mRNA  and  protein  levels  of  RANTES 
w e r e  i n c r e a s e d  i n  a  g e n d e r - d e p e n d e n t  f a s h i o n  i n  W A T  o f  
o b e s i t y .  R A N T E S  l e v e l s  w e r e  p a r t i c u l a r l y  e l e v a t e d  i n  m a l e  
mice  in  the  stromal/vascular  fraction  of  WAT  as  compared 
with  its  adipocyte  fraction.  In  addition,  monoclonal  anti-
bodies directed against RANTES reduced T-cell chemotaxis in-
duced  by  media  conditioned  by  WAT  isolated  from  obese 
male mice. These findings underscore the role of RANTES-in-
duced T-cell chemotaxis by WAT in obesity and suggest an 
opportunity  for  pharmacological  interventions  (27).
    The transcription factor PPAR is a member of steroid re-
ceptor superfamily and has three subtypes named α, δ/β, 
γ (28). Specially, PPARγ is characterized originally as a key 
regulation of adipocyte differentiation and lipid metabolism. 
And it has been shown in macrophage foam cells in athero-Cordycepin Suppresses Expression of Diabetes Regulating Genes by Inhibition of Inflammation
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sclerotic  plaques  (29). 
  As shown in Fig. 3, cordycepin decreased diabetes regulat-
ing genes such as 11β-HSD1, RANTES, and PPARγ in acti-
vated  macrophages.
    IL-1  receptor  antagonist  (IL-1ra)  is  a  antagonist  to  the 
pro-inflammatory  cytokine  IL-1  receptor,  anti-inflammatory 
cytokine, and it is commonly thought to play an important 
role in the regulation of inflammatory responses, as corrobo-
rated by the enhanced sensitivity of IL-1ra knock-out mice to 
septic shock and their predisposition to the spontaneous de-
velopment  of  inflammatory  disorders  (30,31).  IL-1ra  mRNA 
may contribute to regulation of IL-1ra synthesis that another 
mechanism  may  involve  inefficient  functioning  of  poly-
adenylation determinants present in the distal portion of the 
IL-1ra  3’-  untranslated  region  (3’-UTR)  (32). 
    Cordycepin  is  an  inhibitor  of  transcription  and  poly-
adenylation (33), so that gene expression of IL-1ra in our data 
r e m a i n e d  u n p r o c e s s e d  ( d a t a  n o t  s h o w n ) .
    Intracellular adhesion molecules (ICAMs), ICAM-1, ICAM-2 
and ICAM-3, are cell surface ligands for leukocyte integrins. 
They are crucial in the binding of lymphocytes and other leu-
kocytes  to  certain  cells  including  antigen-presenting  cells 
(APCs).  Cordycepin  consistently  suppressed  expression  of 
ICAM-1 surface molecule in macrophages (Fig. 5A). The B7 
family plays an important role as a co-stimulatory  factor in 
A P C s .  C o r d y c e p i n  t r e a t m e n t  h a d  a n o t h e r  m a j o r  e f f e c t  o n  
co-stimulatory molecules B7-1/-2 by strongly down-regulating 
the surface levels of B7-1/-2 molecules in macrophage cells 
(Fig. 5B, C). All these molecules have been described to be 
of  major  importance  in  APC  function  (34,35).
    In conclusion, we have demonstrated that cordycepin pos-
sessed anti-inflammatory and anti-diabetic effects on macro-
phages. Our findings are supported by inhibitory activity of 
cordycepin on the NF-κB pathway and other bioactive sub-
stances, as well as inhibited expression of diabetes regulating 
genes.
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